Chittorgarh.com Logo
FREE Account Opening + No Clearing Fees + Rs 999 API Access
Loading...

Vivo Collaboration IPO Details

Issue Open Dec 20, 2021
Issue Close Dec 23, 2021
IPO Price ₹82
Face Value ₹10
IPO Size ₹4.40 Cr
Listing At NSE SME
IPO Lot Size 1600
Open an Instant Account with Zerodha
  1. vivo Strengthens its Global Presence with User-oriented Innovation and Strategic Partnerships Designed to Inspire Joy

    Mon, 10 Jan 2022 17:33:00 GMT

    In addition, vivo has implemented a strategic development plan to manage long-term and mutually beneficial collaboration with international partners. In 2021, vivo realized its strategic ...

  2. Pfizer/Beam Deal Highlights In Vivo Potential

    Tue, 11 Jan 2022 10:01:00 GMT

    “The base editing programs to be evaluated as part of the collaboration will leverage Beam’s proprietary in vivo delivery technologies, which use messenger RNA (mRNA) and lipid nanoparticles ...

  3. Beam gains 8% on collaboration with Pfizer to advance in vivo programs for rare diseases

    Mon, 10 Jan 2022 03:57:00 GMT

    Beam Therapeutics (NASDAQ:BEAM) perks up 8% premarket after announcing an exclusive four-year research collaboration with Pfizer (NYSE:PFE), focused on in vivo base editing programs for three ...

  4. Moderna Forms Oncology Collaboration With Carisma Therapeutics >MRNA

    Mon, 10 Jan 2022 12:12:00 GMT

    biotechnology company best known for its Covid-19 vaccine, said the collaboration expands its oncology pipeline with a differentiated in-vivo cell-therapy approach. Moderna said it will make a $45 ...

  5. Moderna collaborates with Carisma to develop in vivo CAR-M therapeutics for oncology

    Sun, 09 Jan 2022 23:04:00 GMT

    Moderna (NASDAQ:MRNA) and Carisma Therapeutics have entered into a strategic collaboration agreement to discover, develop and commercialize in vivo engineered chimeric antigen receptor monocyte ...

  6. Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

    Mon, 10 Jan 2022 03:33:00 GMT

    "We are excited to begin this collaboration with Carisma to further expand our oncology pipeline with a differentiated in vivo cell-therapy approach," said Stephen Hoge, President of Moderna.

  7. vivo Strengthens its Global Presence with User-oriented Innovation and Strategic Partnerships Designed to Inspire Joy

    Mon, 10 Jan 2022 17:10:00 GMT

    In addition, vivo has implemented a strategic development plan to manage long-term and mutually beneficial collaboration with international partners. In 2021, vivo realized its strategic partnership ...

  8. Moderna, Inc.: Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology

    Mon, 10 Jan 2022 04:32:00 GMT

    Collaboration will combine Carisma's engineered macrophage technology with Moderna's mRNA and LNP technologies to generate and develop in vivo CAR-M therapeutics Multi-year research collaboration ...

Vivo Collaboration IPO Alerts

1. Vivo Collaboration IPO Listing Date & Info  Thursday, December 30, 2021 10:17:03 AM

The IPO Shares of Vivo Collaboration Solutions Ltd IPO are proposed to list on Friday, December 31, 2021 at NSE SME. The public issue of Vivo Collaboration IPO was opened on Dec 20, 2021 and closed for subscription on Dec 23, 2021. Vivo Collaboration IPO Listing Date and Information:

Vivo Collaboration Solutions Ltd Listing Date

Listing DateFriday, December 31, 2021
BSE Script Code
NSE SymbolVIVO
Listing In
ISININE0IA701014
Issue Price₹82 Per Equity Share
Face Value₹10 Per Equity Share

2. Vivo Collaboration IPO Allotment Status  Tuesday, December 28, 2021 9:00:46 PM

The allotment status of Vivo Collaboration Solutions Ltd IPO is now available online. The public issue of Vivo Collaboration IPO was open on Dec 20, 2021 and closed for subscription on Dec 23, 2021. The equity shares of the company to be list at NSE SME.

3. Vivo Collaboration IPO Opens  Wednesday, December 15, 2021 9:45:05 PM

Vivo Collaboration Solutions Limited is entering in the capital market with an IPO of 536,000 Equity Shares of Rs 10 aggregating up to Rs 4.40 Crore. The price for the issue has been set at Rs 82 Per Equity Share.

The issue opens on Dec 20, 2021 and closes for subscription on Dec 23, 2021. The equity shares of the company to be list at NSE SME.

4. Vivo Collaboration IPO Closes  Wednesday, December 15, 2021 9:45:05 PM

The issue of Vivo Collaboration Solutions Limited opens on Dec 20, 2021 and closes for subscription on Dec 23, 2021. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 82 Per Equity Share.

Vivo Collaboration IPO News & Events FAQs

The Vivo Collaboration IPO is proposed to open on Dec 20, 2021. The IPO application ends on Dec 23, 2021.

Retail investors can apply in the retail or non-institutional investor category from Dec 20, 2021 to Dec 23, 2021. The Vivo Collaboration IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Vivo Collaboration IPO will open for subscription on Dec 20, 2021. The public issue will close on Dec 23, 2021.